Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis | Zendy

John H. Kempen | Zendy; Michael M. Altaweel | Zendy; Janet T. Holbrook | Zendy; Elizabeth A. Sugar | Zendy; Jennifer E. Thorne | Zendy; Douglas A. Jabs | Zendy

Open Access

Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis

Author(s) -

John H. Kempen,

Michael M. Altaweel,

Janet T. Holbrook,

Elizabeth A. Sugar,

Jennifer E. Thorne,

Douglas A. Jabs

Publication year - 2017

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2017.5103

Subject(s) - fluocinolone acetonide , medicine , visual acuity , uveitis , implant , ophthalmology , randomized controlled trial , triamcinolone acetonide , intermediate uveitis , surgery , anterior uveitis

A randomized clinical trial comparing fluocinolone acetonide implant vs systemic corticosteroids and immunosuppression for treatment of severe noninfectious intermediate, posterior, and panuveitides did not result in a significant difference in visual acuity at 2 and 4.5 years; longer-term outcomes are not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research